News tagged with american society of clinical oncology

Related topics: cancer · cancer patients · chemotherapy

ASCO: Trametinib improves survival in metastatic melanoma

(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with improved progression-free ...

Jun 05, 2012
popularity0 comments 0

Subscribe to rss feed